Novo Nordisk urges customers to purchase medications solely from authorized pharmacies with valid prescriptions after a theft of products, including semaglutide and insulin treatments, during transportation. The company is cooperating with authorities and reinforcing supply chain safeguards. CDSCO has issued an alert, advising caution and vigilance in procuring Novo Nordisk products from trusted sources due to potential compromised quality.